Financials
- Market Capitalization 3.85 B
- Employee 182
- Founded 2002
- CEO N/A
- Website www.catalystpharma.com
- Headquarter Delaware, United States
- FIGI BBG000GZDC67
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1450 | EWTX Edgewise Therapeutics, Inc. - Common Stock | 39.73 USD | -3.73% | -7.54% | +11.26% | +160.87% | 4.27 B USD | ||
| 1529 | NAMS NewAmsterdam Pharma Company N.V. - Ordinary Shares | 33.29 USD | +0.03% | -9.19% | +8.97% | -8.22% | 3.89 B USD | ||
| 1554 | TLX Telix Pharmaceuticals Limited - American Depositary Shares | 11.02 USD | +0.46% | -4.09% | +14.20% | +74.64% | 3.73 B USD | ||
| 1568 | RLAY Relay Therapeutics, Inc. - Common Stock | 19.08 USD | +1.87% | -3.20% | +27.28% | +437.46% | 3.66 B USD |
Frequently asked questions about Catalyst Pharmaceuticals, Inc. - Common Stock
What is the Catalyst Pharmaceuticals, Inc. - Common Stock stock price today?
The current price of Catalyst Pharmaceuticals, Inc. - Common Stock (CPRX) is 31.49. Over the past 24 hours, the stock has changed by +0.03%. Follow the CPRX chart for real-time price dynamics.
What is the stock ticker of Catalyst Pharmaceuticals, Inc. - Common Stock?
Catalyst Pharmaceuticals, Inc. - Common Stock trades under the ticker CPRX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Catalyst Pharmaceuticals, Inc. - Common Stock stock going up?
CPRX has changed by +0.06% over the last week, +0.41% over the last month, and +48.47% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Catalyst Pharmaceuticals, Inc. - Common Stock net income for the last quarter?
Catalyst Pharmaceuticals, Inc. - Common Stock reported net income of 63.73 M for the last quarter. The previous quarter showed 52.7 M, which means net income changed by +20.94%.
How many employees does Catalyst Pharmaceuticals, Inc. - Common Stock have?
As of the latest available data, Catalyst Pharmaceuticals, Inc. - Common Stock has 182 employees. Workforce size can provide additional context about the company's scale and operations.
What is Catalyst Pharmaceuticals, Inc. - Common Stock EBITDA?
Catalyst Pharmaceuticals, Inc. - Common Stock EBITDA is 92.71 M, and its EBITDA margin is 62.06%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Catalyst Pharmaceuticals, Inc. - Common Stock stock?
You can buy Catalyst Pharmaceuticals, Inc. - Common Stock (CPRX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Catalyst Pharmaceuticals, Inc. - Common Stock stock?
Investing in Catalyst Pharmaceuticals, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CPRX chart and related analysis on metatrader.com as part of your research.